News

Modeling and simulation has played an important role in supporting regulatory approvals of caplacizumab for treatment of acquired thrombotic thrombocytopenic purpura (aTTP). For example, in 2018 the EMA agreed that clinical studies

We are very happy to welcome Moriah Pellowee, Associate Consultant, in our team. Moriah’s research experience includes physiological based pharmacokinetic modeling (PBPK), mechanistic modelling of inhaled drugs, development of a virtual bioequivalence

We, at Pharmetheus, congratulate all 2021 ISoP Fellows Jonathan French, Lena Friberg, Siv Jönsson & Saroja Ramanujan who so clearly deserve this recognition for their professional excellence, sustained and substantial impact in

Can one describe tumor and host body responses to the epidermal growth factor receptor-tyrosine kinase inhibitor gefitinib and the MET inhibitors capmatinib and S49076 in mono- and combination therapies? Read the collaboration paper

Pharmetheus is offering virtual professional consulting sessions (~30 min), free of charge, between the 3rd to 17th of November, in connection to the ACoP 12, 2021 meeting. Note that these sessions are open to

We’re ever proud of our Chairman and advisor Prof Mats Karlsson. This year marks 20 years since he became the world’s first Professor of Pharmacometrics. In his words: “If I am to

We extend a warm welcome to Ricardo Danza, new Analyst System Developer at Pharmetheus. Ricardo’s areas of expertise include programming, algorithms, Machine Learning, and languages such as R, C++, and Python. Ricardo

Pharmetheus has for the third time been awarded the title DI Gazelle.The title is awarded by the Swedish business publication Dagens Industri to Sweden’s fastest organically growing small and medium sized companies

We are glad to welcome Sami Ullah, Associate Consultant, to Pharmetheus. Sami will be based in Uppsala. His research experience includes population PK modeling, primarily in the area of infectious diseases, including